Healthlead Public Company Limited, together with its subsidiaries, engages in developing, importing, and distributing drugs, pharmaceuticals, cosmetic products, dietary supplements, medical devices, other healthcare products. It offers medicines, medical supplies and devices, as well as disinfectant and deodorizing products, masks, and sterilization products under the iCare, Pharmax, and Super Drug brands; and healthcare product innovations under PRIME, Besuto, and BOMSKIN brands. The company was incorporated in 2018 and is based in Nonthaburi, Thailand.
Frequently asked questions
What sector does Healthlead Public Company Limited (HL) operate in?
Healthlead Public Company Limited belongs to the Healthcare sector and operates in the Pharmaceutical Retailers industry.
What is Healthlead Public Company Limited (HL) current stock price?
As of the latest data, Healthlead Public Company Limited stock price is THB 5.45, with a previous close of THB 5.60. Healthlead Public Company Limited lost -THB 0.15 in the last trading session, representing a -2.68% loss.
What is Healthlead Public Company Limited (HL) current market capitalization?
Healthlead Public Company Limited market cap is approximately 1.38 billion.
What is Healthlead Public Company Limited (HL) Earnings Per Share (EPS)?
The trailing EPS is THB 0.28.
What is Healthlead Public Company Limited (HL) Price-to-Earnings (P/E) ratio?
Healthlead Public Company Limited current P/E ratio is 19.46.
Does Healthlead Public Company Limited (HL) pay dividends?
Yes. Healthlead Public Company Limited pays annual dividends with an annualized yield of 4.04% and an estimated annual payout of THB 0.22 per share.
When is the next ex-dividend date for Healthlead Public Company Limited (HL)?
The next ex-dividend date is scheduled for March 11, 2027.
What is Healthlead Public Company Limited (HL) beta (volatility) score?
Healthlead Public Company Limited has a beta of 0.290, indicating lower volatility than the overall market.
